Results
1 -
10 of
23TGF Beta Receptors, Cancer Therapeutic Targets Immune Checkpoint Combinations with Inflammatory Pathway Modulators, Early Phase Cancer Immunotherapy Targeted Therapies Against Growth Factor Signaling in Breast Cancer, Translational Research in Breast Cancer EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-??/Smad and ROS signaling, Cellular and Molecular Life Sciences Galunisertib modifies the liver fibrotic composition in the Abcb4Ko mouse model, Archives of Toxicology Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors, Cancer Chemotherapy and Pharmacology Phase 1b study of galunisertib in combination with gemcitabine in Japanese patients with metastatic or locally advanced pancreatic cancer, Cancer Chemotherapy and Pharmacology Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?, Cancer Immunology, Immunotherapy Norepinephrine induced epithelialu2013mesenchymal transition in HT-29 and A549 cells in vitro, Journal of Cancer Research and Clinical Oncology A novel culture system for adult porcine intestinal crypts, Cell and Tissue Research